Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer
16 mai 2018 16h10 HE
|
Biothera Pharmaceuticals, Inc.
EAGAN, Minn., May 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective...